Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Nov 19, 2022 1:47pm
268 Views
Post# 35112751

Half day of upside and the pump exaggeration of facts begins

Half day of upside and the pump exaggeration of facts begins.20 that must be a typo , you mean .02 in December , the big players just dumped more shares on Friday for suckers to buy.No results yet , it will still be months if approved and Tetra shareholders will not see a penny of profit from Reduvo , it will be sold off to keep Guys wage going and pay the bills , 140,000,000 deficit and payments due at 15 % interest . Guy will then drain the bank of Tetra again on another idea and keep shareholders in suspense over the next big so called dream milestone . Its a label anouncement , nothing , check back in March , April 2023 . Health Canada states it can take 1 to 2 years to obtain DIN and Health Canada did not confirm final acceptance of Reduvo application till June 2nd , 2021 
<< Previous
Bullboard Posts
Next >>